$VISK 4 SEC Filings

Filed On	Filing
27 Mar 2026	Form 4: Icahn Carl C, 10% owner and 2 others Returned 39,277 shares to the issuer · Received 5,658,396 shares as a grant or award · Received 7,407,489 shares as a grant or award
16 Jun 2023	Form 4: Read Randolph C, Director Bought 15,000 shares ($1.99K) · Bought 84,550 shares ($11.9K)
17 Aug 2021	Form 4: Couchman Jonathan, 10% owner and 3 others Sold 107,500 shares ($41.9K)
18 Nov 2020	Form 4: Read Randolph C, Director Bought 50,450 shares ($7.62K) · Bought 50,000 shares ($7.88K)
17 Nov 2020	Form 4: Bleznick Jordan, Director Bought 100,000 shares ($15.4K)
14 Oct 2020	Form 4: Icahn Carl C, 10% owner Received 29,457,750 shares by exercise · Received 39,277 shares by exercise
26 Aug 2020	Form 4: Couchman Jonathan, 10% owner and 6 others Sold 52,100 shares ($9.56K) · Sold 25,000 shares ($4.78K)
06 Aug 2020	Form 4: Couchman Jonathan, 10% owner and 6 others Bought 506,292 shares ($101K)
27 Mar 2020	Form 4: Couchman Jonathan, 10% owner and 2 others Bought 19,709 shares ($2.66K) · Bought 2,678 shares ($375) · Bought 469,551 shares ($65.7K) · 1 more
14 Feb 2019	Form 4: Couchman Jonathan, 10% owner and 2 others Bought 51,000 shares ($12.8K)
09 Jan 2019	Form 4: Couchman Jonathan, 10% owner and 2 others Bought 20,600 shares ($5.25K) · Bought 8,800 shares ($2.28K) · Bought 67,200 shares ($17.5K) · 15 more
09 Jan 2019	Form 4: Couchman Jonathan, 10% owner and 2 others Bought 4,700 shares ($1.22K) · Bought 185,700 shares ($48.3K) · Bought 3,000 shares ($780) · 27 more
29 Nov 2016	Form 4: Icahn Carl C, 10% owner Bought 694,023 shares ($281K) · Disposed of 1 Total Return Swap (Long Position Expiration)
28 Nov 2014	Form 4: Icahn Carl C, 10% owner Received 694,023 shares by exercise · Disposed of 694,023 shares (Other Transaction) · Acquired 1 Total Return Swap (Other Transaction) · 3 more
19 Sep 2013	Form 4: Lebuhn Robert, Director Sold 34,807 shares ($60.5K) · Sold 21,119 shares ($35.6K)
25 Jan 2013	Form 4: Rackear Andrew D., VP and General Counsel Received 4,686 shares as a grant or award
25 Jan 2013	Form 4: Buchbinder Aby, VP, Clinical Development Received 3,748 shares as a grant or award
25 Jan 2013	Form 4: Conover Charles, SVP, R&D Program Management Received 2,343 shares as a grant or award
04 Jan 2013	Form 4: Young Richard A, Director Granted 20,129 Stock Option (Right to Buy)
04 Jan 2013	Form 4: Deuel Thomas, Director Granted 20,129 Stock Option (Right to Buy)

Comments